| Purpose | Announcement Date | Meeting Date |
|---|---|---|
| EGM | 22 Sep 2026 | 24 Oct 2026 |
| Venmax Drugs and Pharmaceuticals Limited has informed exchange about the meeting of equity shareholders of the Company pursuant to the order passed by Hon. NCLT, Hyderabad bench II in respect of Scheme of Amalgamation of Hatri Pharma Private Limited with Venmax Drugs and Pharmaceuticals Limited. Venmax Drugs and Pharmaceuticals Limited has informed the Bombay Stock Exchange regarding Proceedings of court convened General Meeting held today i.e. October 24, 2026. (As per BSE announcement dated on : 24.10.2026). Venmax Drugs and Pharmaceuticals Limited has submitted the Exchange a copy if Scrutinizer report along with voting results of court convened General Meeting held on October 24, 2026. (As per BSE announcement dated on : 26.10.2026) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
